Johnson & Johnson Agrees to $8.9 Billion Settlement in Talcum Powder Lawsuit
WEDNESDAY, April 5, 2023 (HealthDay News) — Tens of thousands of people suing Johnson & Johnson may get some relief after the company announced Tuesday that it will pay $8.9 billion to settle lawsuits that have been going for more than a decade.The s…
Learn MoreUna nueva oportunidad para dos pacientes con cáncer de pulmón tras un doble trasplante de pulmón pionero
MIÉRCOLES, 15 de marzo de 2023 (HealthDay News) — Tannaz Ameli, una enfermera jubilada, recibió un diagnóstico de cáncer de pulmón en etapa 4 el invierno pasado. Cuando la quimioterapia no funcionó, los médicos le recomendaron cuidados paliativos.Per…
Learn MoreHormone Therapy Not Linked to Lung Cancer in Postmenopausal Women
FRIDAY, March 17, 2023 (HealthDay News) — For postmenopausal women, hormone therapy (HT) is not associated with the risk for lung cancer development, and lower risk was seen with higher cumulative dosage and long-term use, according to a study publis…
Learn MoreHormone Therapy Not Linked to Lung Cancer in Postmenopausal Women
FRIDAY, March 17, 2023 (HealthDay News) — For postmenopausal women, hormone therapy (HT) is not associated with the risk for lung cancer development, and lower risk was seen with higher cumulative dosage and long-term use, according to a study publis…
Learn MoreNew Lease on Life for Two Lung Cancer Patients After Pioneering Double-Lung Transplant
WEDNESDAY, March 15, 2023 (HealthDay News) — Retired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. She and her husband…
Learn MoreSBRT Well Tolerated, Effective for Primary Lung Neuroendocrine Tumor
THURSDAY, Feb. 23, 2023 (HealthDay News) — For patients with primary lung neuroendocrine tumor (LNET), stereotactic body radiotherapy (SBRT) is well tolerated and provides excellent locoregional control, according to a study published online Jan. 25 …
Learn MorePositive Five-Year Outcomes Seen for Nivolumab in Resectable Lung Cancer
WEDNESDAY, Feb. 15, 2023 (HealthDay News) — For patients with resectable non-small cell lung cancer (NSCLC), neoadjuvant nivolumab is associated with positive five-year outcomes, according to a study published online Feb. 15 in Clinical Cancer Resear…
Learn MoreEn la cirugía para el cáncer de pulmón en etapa temprana, menos quizá sea más
VIERNES, 10 de febrero de 2023 (HealthDay News) — Algunos pacientes que se someten a una cirugía para un cáncer de pulmón en etapa temprana quizá no tengan que perder un lóbulo completo de su pulmón, muestra una investigación reciente.Los resultados …
Learn MoreAI Improves Detection of Actionable Lung Nodules on Chest Radiographs
FRIDAY, Feb. 10, 2023 (HealthDay News) — Artificial intelligence (AI)-based computer-aided detection (CAD) software improves the detection of actionable lung nodules on chest radiographs, without increased false-referral rates, according to a study p…
Learn MoreLess May Be More When It Comes to Surgery for Early-Stage Lung Cancer
FRIDAY, Feb. 10, 2023 (HealthDay News) — Some patients having surgery for early-stage lung cancer may no longer need to lose an entire lobe of their lung, new research shows.The study results are from a phase 3 clinical trial sponsored by the Allianc…
Learn More